John Schaetzl will be greatly missed
John brought his extensive private sector experience to bear on the issue of how to sustainably expand access to medicine in low- and middle-income countries. This included his decade with GE Asset Management, during which he managed global life-science investment funds – advising large foundations, government agencies and fund managers on investing that supports economic development and sustainable access-to-health outcomes. He was previously an executive at the pharmaceutical company Bayer.Â
John will be remembered fondly by all who worked with him at the Access to Medicine Foundation, and by his fellow members of the Supervisory Board. Our thoughts and sympathies are with his friends and family.Â
“Since John joined the Supervisory Board in 2014, his insights, advice and guidance have been invaluable to both me and the Foundation. He was an amazing leader, perpetually full of positive energy, and always generous with both his time and knowledge. His loss is deeply felt.”